Earendil Labs
PrivateLast Round
Series B
Mar 20, 2026
Total Funding Raised
$861.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Earendil Labs is a biotechnology company that develops an AI-driven platform for biologics discovery and development to treat autoimmune diseases and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Earendil Labs Comparables
Compare Earendil Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BigHat Biosciences | 87% | |
| LabGenius Therapeutics | 82% | |
| Alphabet Inc. | 81% |
Earendil Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 20, 2026 | ||||
| Series A | Jun 22, 2022 |
Earendil Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DST Global | Series B |
| Hillhouse Investment | Series A, Series B |
| Dimension | Series B |
| 渶策资本 | Series B |
| 5Y Capital | Series A |
| Luminous Ventures | Series B |
| Dimensional Fund Advisors | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2026
Partnered with Helixon Therapeutics to advance therapeutic programs using AI.
- Mar 20, 2026
$787M round led by Dimensional Fund Advisors and Sanofi.
Earendil Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Earendil Labs's valuation, stock price, and market status.
Is Earendil Labs a public or private company?
Earendil Labs is a private company.
What is the current stock price of Earendil Labs?
Earendil Labs is a private company with no public stock price. No recent secondary market data is available.
How much is Earendil Labs worth (valuation)?
Valuation information for Earendil Labs is not publicly available.
Can I buy Earendil Labs stock?
Earendil Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Earendil Labs's last funding round?
Earendil Labs's most recent funding round was Early Funding on March 20, 2026.
Who are the main investors in Earendil Labs?
Key investors in Earendil Labs include DST Global, Dimension, 5Y Capital, Dimension.
Will Earendil Labs IPO soon?
No public IPO plans have been announced for Earendil Labs.
How can I track Earendil Labs secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Earendil Labs's secondary market activity and sign up for updates.